142 related articles for article (PubMed ID: 27463607)
1. Platelet surface expression of SDF-1 is associated with clinical outcomes in the patients with cardiovascular disease.
Rath D; Chatterjee M; Bongartz A; Müller K; Droppa M; Stimpfle F; Borst O; Zuern C; Vogel S; Gawaz M; Geisler T
Platelets; 2017 Jan; 28(1):34-39. PubMed ID: 27463607
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery.
Rath D; Chatterjee M; Borst O; Müller K; Stellos K; Mack AF; Bongartz A; Bigalke B; Langer H; Schwab M; Gawaz M; Geisler T
Eur Heart J; 2014 Feb; 35(6):386-94. PubMed ID: 24168792
[TBL] [Abstract][Full Text] [Related]
3. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
4. Platelet surface expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 is associated with clinical outcomes in patients with coronary artery disease.
Rath D; Chatterjee M; Borst O; Müller K; Langer H; Mack AF; Schwab M; Winter S; Gawaz M; Geisler T
J Thromb Haemost; 2015 May; 13(5):719-28. PubMed ID: 25660395
[TBL] [Abstract][Full Text] [Related]
5. Platelet expression of stromal-cell-derived factor-1 (SDF-1): an indicator for ACS?
Wurster T; Stellos K; Haap M; Seizer P; Geisler T; Otton J; Indermuehle A; Ishida M; Schuster A; Nagel E; Gawaz M; Bigalke B
Int J Cardiol; 2013 Mar; 164(1):111-5. PubMed ID: 21737155
[TBL] [Abstract][Full Text] [Related]
6. Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease.
Müller K; Aichele S; Herkommer M; Bigalke B; Stellos K; Htun P; Fateh-Moghadam S; May AE; Flather M; Gawaz M; Geisler T
Atherosclerosis; 2010 Nov; 213(1):256-62. PubMed ID: 20728084
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 Expression Level in Circulating Platelets is not Significantly Associated with Outcomes in Symptomatic Coronary Artery Disease.
Rath D; Geisler T; Gawaz M; Vogel S
Cell Physiol Biochem; 2017; 43(4):1627-1633. PubMed ID: 29041001
[TBL] [Abstract][Full Text] [Related]
9. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
Stellos K; Bigalke B; Langer H; Geisler T; Schad A; Kögel A; Pfaff F; Stakos D; Seizer P; Müller I; Htun P; Lindemann S; Gawaz M
Eur Heart J; 2009 Mar; 30(5):584-93. PubMed ID: 19109356
[TBL] [Abstract][Full Text] [Related]
10. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
11. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction.
Ahn SG; Lee SH; Yoon JH; Kim WT; Lee JW; Youn YJ; Ahn MS; Kim JY; Yoo BS; Yoon J; Choe KH
JACC Cardiovasc Interv; 2012 Mar; 5(3):259-67. PubMed ID: 22440490
[TBL] [Abstract][Full Text] [Related]
12. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
13. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y
Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306
[TBL] [Abstract][Full Text] [Related]
14. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
Chikata Y; Iwata H; Miyosawa K; Naito R; Koike T; Moriya S; Yasuda H; Funamizu T; Doi S; Endo H; Wada H; Ogita M; Dohi T; Kasai T; Isoda K; Okazaki S; Miyauchi K; Minamino T
Cardiovasc Diabetol; 2024 Mar; 23(1):114. PubMed ID: 38555431
[TBL] [Abstract][Full Text] [Related]
16. Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: A comparable and additive study.
Seo HJ; Ki YJ; Han MA; Choi DH; Ryu SW
Platelets; 2015; 26(7):665-71. PubMed ID: 25383727
[TBL] [Abstract][Full Text] [Related]
17. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
18. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
Atherosclerosis; 2016 Apr; 247():105-10. PubMed ID: 26896722
[TBL] [Abstract][Full Text] [Related]
19. Platelet surface expression of cyclophilin A is associated with increased mortality in patients with symptomatic coronary artery disease.
Rath D; von Ungern-Sternberg S; Heinzmann D; Sigle M; Monzien M; Horstmann K; Schaeffeler E; Winter S; Müller K; Groga-Bada P; Zdanyte M; Borst O; Zernecke A; Gawaz M; Martus P; Schwab M; Geisler T; Seizer P
J Thromb Haemost; 2020 Jan; 18(1):234-242. PubMed ID: 31519036
[TBL] [Abstract][Full Text] [Related]
20. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
